Lymphangiographic study of pelvic adenopathy regression in a phase II trial of methyl-hydroxy-ellipticine in HIV1-AIDS complex.
Mathé
G
G
Hallard
M
M
Pontiggia
P
P
D000386:AIDS-Related Complex / Q000188:drug therapy*; D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004611:Ellipticines / Q000627:therapeutic use*; D006801:Humans; D008220:Lymphography; D008297:Male; D010386:Pelvic Neoplasms / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004611:Ellipticines; C027767:elliptinium